Stocksigma LogoStocksigma Logo

Max Healthcare Approves PRSU Scheme 2026 and Strategic MOA Alterations

Max Healthcare Institute shareholders approved the Performance Linked Restricted Stock Unit (PRSU) Scheme 2026 via postal ballot on 19th Oct'26

Max Healthcare Approves PRSU Scheme 2026 and Strategic MOA Alterations

Max Healthcare Institute Ltd · Others (Uncategorized) · 20 Oct 2026, 3:27 am

Max Healthcare Approves PRSU Scheme 2026 and Strategic MOA Alterations Max Healthcare Institute shareholders approved the Performance Linked Restricted Stock Unit (PRSU) Scheme 2026 via postal ballot on 19th Oct'26. The scheme covers up to 73.50 lakh equity shares (~0.76% of paid-up capital as of 13th Aug'26) for eligible employees of the company and subsidiaries at an exercise price equal to face value (₹10/share). Additionally, members approved altering the Memorandum of Association's Main Objects Clause to expand into medical education/colleges, pharmaceuticals and radiopharmaceuticals manufacturing via particle accelerator facilities, and in-house food and beverage services.

Original exchange filing (PDF)

More announcements from Max Healthcare Institute Ltd

All Max Healthcare Institute Ltd announcements